Phentolamine inhibition of rat seminal vesicle response to dopamine-mimetic drugs: alpha-adrenoceptor implication or lack of specificity?
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002217:Carbachol / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D006220:Haloperidol / Q000494:pharmacology; D048288:Imidazolines; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects*; D010646:Phentolamine / Q000494:pharmacology*; D051381:Rats; D011941:Receptors, Adrenergic / Q000502:physiology*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects / Q000502:physiology*; D012669:Seminal Vesicles / Q000187:drug effects; D013469:Sulpiride / Q000494:pharmacology
D002395:Catecholamines; D048288:Imidazolines; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D013469:Sulpiride; D002217:Carbachol; C011775:(3,4-dihydroxyphenylamino)-2-imidazoline; D006220:Haloperidol; D001058:Apomorphine; D004298:Dopamine; D010646:Phentolamine